Control Bionics Ltd (CBL)

Currency in AUD
0.044
+0.001(+2.33%)
Closed·
CBL Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
CBL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0440.045
52 wk Range
0.0260.105
Key Statistics
Bid/Ask
0.043 / 0.045
Prev. Close
0.043
Open
0.044
Day's Range
0.044-0.045
52 wk Range
0.026-0.105
Volume
63.68K
Average Volume (3m)
179.6K
1-Year Change
-14%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CBL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Control Bionics Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Control Bionics Ltd Company Profile

Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, and internationally. The company offers NeuroNode Trilogy, NeuroNode Duo, and Eye-gaze Duo systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. It also provides Cosmos Connect, a small portable control device that can be used with a Windows display device; NeuroNode, a wireless wearable sensor that gives the user the ability to access their technology by bioelectric signals or spatial movements; Uno Touch, a speech generating device; and NeuroNode Duo, a wireless sensor. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is headquartered in Cremorne, Australia.

Compare CBL to Peers and Sector

Metrics to compare
CBL
Peers
Sector
Relationship
P/E Ratio
−1.9x−3.0x−0.5x
PEG Ratio
−0.05−0.030.00
Price/Book
2.0x2.9x2.6x
Price / LTM Sales
2.5x3.7x3.2x
Upside (Analyst Target)
-153.5%43.8%
Fair Value Upside
Unlock15.6%5.1%Unlock

Earnings

Latest Release
Feb 25, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
2.90M / --
EPS Revisions
Last 90 days

CBL Income Statement

FAQ

What Is the Control Bionics (CBL) Stock Price Today?

The Control Bionics stock price today is 0.04

What Stock Exchange Does Control Bionics Trade On?

Control Bionics is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Control Bionics?

The stock symbol for Control Bionics is "CBL."

What Is the Control Bionics Market Cap?

As of today, Control Bionics market cap is 13.26M.

What Is Control Bionics's Earnings Per Share (TTM)?

The Control Bionics EPS (TTM) is -0.03.

From a Technical Analysis Perspective, Is CBL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Control Bionics Stock Split?

Control Bionics has split 0 times.

How Many Employees Does Control Bionics Have?

Control Bionics has 0 employees.

What is the current trading status of Control Bionics (CBL)?

As of 18 July 2025, Control Bionics (CBL) is trading at a price of 0.04, with a previous close of 0.04. The stock has fluctuated within a day range of 0.04 to 0.05, while its 52-week range spans from 0.03 to 0.11.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.